Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetSubstance-K receptor
LigandBDBM50045035
Substrate/Competitorn/a
Meas. Tech.ChEBML_141787
IC50 388±n/a nM
Citation Kucharczyk, NThurieau, CPaladino, JMorris, ADBonnet, JCanet, EKrause, JERegoli, DCouture, RFauchère, JL Tetrapeptide tachykinin antagonists: synthesis and modulation of the physicochemical and pharmacological properties of a new series of partially cyclic analogs. J Med Chem36:1654-61 (1993) [PubMed]
More Info.:Get all data from this article,  Assay Method
 
Substance-K receptor
Name:Substance-K receptor
Synonyms:NK-2 receptor | NK-2R | NK2R_RAT | Neurokinin 2 receptor | Neurokinin A receptor | Neurokinin NK2 | SKR | Substance-K receptor | Tac2r | Tachykinin receptor 2 | Tacr2
Type:Enzyme Catalytic Domain
Mol. Mass.:43868.63
Organism:Rattus norvegicus (Rat)
Description:Neurokinin NK2 TACR2 Murine::P16610
Residue:390
Sequence:
MGTRAIVSDANILSGLESNATGVTAFSMPGWQLALWATAYLALVLVAVTGNATVIWIILA
HERMRTVTNYFIINLALADLCMAAFNATFNFIYASHNIWYFGRAFCYFQNLFPITAMFVS
IYSMTAIAADRYMAIVHPFQPRLSAPSTKAIIAGIWLVALALASPQCFYSTITVDEGATK
CVVAWPNDNGGKMLLLYHLVVFVLIYFLPLLVMFGAYSVIGLTLWKRAVPRHQAHGANLR
HLQAKKKFVKAMVLVVLTFAICWLPYHLYFILGTFQEDIYYHKFIQQVYLALFWLAMSST
MYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTEEDRLELTHTPSLSRRVNRCHTKETLFMT
GDMTHSEATNGQVGSPQDGEPAGPICKAQA
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM50045035
n/a
NameBDBM50045035
Synonyms:4-(3-{2-[1-(Benzyl-methyl-carbamoyl)-2-phenyl-ethylcarbamoyl]-2-[2-(3,6-dioxo-2,5-diaza-tricyclo[6.2.2.0*2,7*]dodec-4-yl)-acetylamino]-ethyl}-indol-1-yl)-4-oxo-butyric acid | CHEMBL3144351
TypeSmall organic molecule
Emp. Form.C44H48N6O8
Mol. Mass.788.8873
SMILESCN(Cc1ccccc1)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1cn(C(=O)CCC(O)=O)c2ccccc12)NC(=O)C[C@@H]1NC(=O)[C@@H]2C3CCC(CC3)N2C1=O |r,wU:48.51,11.11,44.47,wD:22.24,THB:46:48:51.50:53.54,(10.95,-12.84,;9.79,-13.85,;10.1,-15.36,;11.55,-15.86,;11.86,-17.37,;13.32,-17.86,;14.47,-16.84,;14.17,-15.33,;12.71,-14.84,;8.33,-13.36,;7.18,-14.38,;8.03,-11.85,;9.19,-10.83,;8.89,-9.32,;10.04,-8.31,;9.74,-6.8,;8.28,-6.3,;7.13,-7.32,;7.43,-8.83,;6.49,-11.83,;5.74,-10.49,;6.52,-9.16,;4.2,-10.47,;3.45,-9.13,;4.23,-7.8,;5.76,-7.66,;6.1,-6.16,;7.52,-5.55,;8.98,-6.04,;7.7,-4.02,;9.11,-3.41,;9.29,-1.88,;8.06,-.96,;10.7,-1.27,;4.78,-5.37,;4.48,-3.86,;3.02,-3.37,;1.86,-4.38,;2.16,-5.89,;3.62,-6.39,;3.41,-11.79,;1.87,-11.78,;1.12,-10.43,;1.09,-13.1,;-.45,-13.08,;-1.21,-11.74,;-2.75,-11.72,;-3.5,-10.38,;-3.53,-13.04,;-4.99,-12.96,;-6.22,-14.05,;-5.59,-15.32,;-4.31,-14.2,;-4.66,-12.28,;-5.44,-11.34,;-2.78,-14.39,;-1.24,-14.41,;-.48,-15.75,)|
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: